ARCHIVES

ACS to Purchase $1.5 Million In animal Interferon, Offer it for Laboratory Studies

This article is from The Cancer Letter archive.

Vol. 10 No. 28 | July 13, 1984

Download PDF Visit The Full Archive

Related Articles

FDA Advisors Oppose Group’s Tamoxifen Trial, But Okay The Idea

July 6, 1990

Novel Four Drug Combination Safe For Lung Cancer Therapy

November 28, 2008

DCE Board Approve Concepts For Contract Recompetitions

November 23, 1984

No Justification Provided: AAUP Demands Reinstatement of Faculty Denied Tenure Renewal at MD Anderson

May 16, 2014

Chemoprevention Concept Approved By DCPC Bard Uses Biological Markers To Assess Risk Modulation

September 27, 1985

In Brief: $100 Million Being Spent On Interferon In U.S., Rauscher Says; DeVita; Criticism Deserved

April 4, 1980